These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32431666)

  • 41. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
    Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
    Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Chronic Kidney Disease with Coronary Heart Disease and Stroke Risks in Patients with Type 2 Diabetes Mellitus: An Observational Cross-sectional Study in Hangzhou, China.
    Sun X; He J; Ji XL; Zhao YM; Lou HY; Song XX; Shan LZ; Kang YX; Zeng WH; Pang XH; Zhang SZ; Ding Y; Ren YZ; Shan PF
    Chin Med J (Engl); 2017 5th Jan 2017; 130(1):57-63. PubMed ID: 28051024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women.
    Tobias DK; Lawler PR; Harada PH; Demler OV; Ridker PM; Manson JE; Cheng S; Mora S
    Circ Genom Precis Med; 2018 Apr; 11(4):e002157. PubMed ID: 29572205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human serum acylcarnitine profiles in different glucose tolerance states.
    Zhang X; Zhang C; Chen L; Han X; Ji L
    Diabetes Res Clin Pract; 2014 Jun; 104(3):376-82. PubMed ID: 24837145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus.
    El-Lebedy D; Rasheed E; Kafoury M; Abd-El Haleem D; Awadallah E; Ashmawy I
    J Diabetes Complications; 2016; 30(4):580-5. PubMed ID: 26965796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study.
    Lim TS; Yun JS; Cha SA; Song KH; Yoo KD; Ahn YB; Park YM; Ko SH
    Korean J Intern Med; 2016 Nov; 31(6):1110-1119. PubMed ID: 27756118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease.
    Lv J; Pan C; Cai Y; Han X; Wang C; Ma J; Pang J; Xu F; Wu S; Kou T; Ren F; Zhu ZJ; Zhang T; Wang J; Chen Y
    Nat Commun; 2024 Jul; 15(1):5729. PubMed ID: 38977723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma acylcarnitine profiling indicates increased fatty acid oxidation relative to tricarboxylic acid cycle capacity in young, healthy low birth weight men.
    Ribel-Madsen A; Ribel-Madsen R; Brøns C; Newgard CB; Vaag AA; Hellgren LI
    Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27694528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of Circulating Cathepsin S and Cardiovascular Disease Among Patients With Type 2 Diabetes: A Cross-Sectional Community-Based Study.
    Jing Y; Shi J; Lu B; Zhang W; Yang Y; Wen J; Hu R; Yang Z; Wang X
    Front Endocrinol (Lausanne); 2021; 12():615913. PubMed ID: 33746900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carnitine levels in valproic acid-treated psychiatric patients: a cross-sectional study.
    Moreno FA; Macey H; Schreiber B
    J Clin Psychiatry; 2005 May; 66(5):555-8. PubMed ID: 15986510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transorgan fluxes in a porcine model reveal a central role for liver in acylcarnitine metabolism.
    Schooneman MG; Ten Have GA; van Vlies N; Houten SM; Deutz NE; Soeters MR
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(3):E256-64. PubMed ID: 26037250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort.
    Lacruz ME; Kluttig A; Tiller D; Medenwald D; Giegling I; Rujescu D; Prehn C; Adamski J; Frantz S; Greiser KH; Emeny RT; Kastenmüller G; Haerting J
    Circ Cardiovasc Genet; 2016 Dec; 9(6):487-494. PubMed ID: 27784734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies.
    Razquin C; Ruiz-Canela M; Clish CB; Li J; Toledo E; Dennis C; Liang L; Salas-Huetos A; Pierce KA; Guasch-Ferré M; Corella D; Ros E; Estruch R; Gómez-Gracia E; Fitó M; Lapetra J; Romaguera D; Alonso-Gómez A; Serra-Majem L; Salas-Salvadó J; Hu FB; Martínez-González MA
    Cardiovasc Diabetol; 2019 Nov; 18(1):151. PubMed ID: 31722714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interventional Left Atrial Appendage Closure Affects the Metabolism of Acylcarnitines.
    Fastner C; Behnes M; Sartorius B; Wenke A; Lang S; Yücel G; Sattler K; Rusnak J; Saleh A; Barth C; Mashayekhi K; Hoffmann U; Borggrefe M; Akin I
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.
    Ganz T; Wainstein J; Gilad S; Limor R; Boaz M; Stern N
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27393712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
    Tomlinson J; Millward A; Stenhouse E; Pinkney J
    Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support.
    Ahmad T; Kelly JP; McGarrah RW; Hellkamp AS; Fiuzat M; Testani JM; Wang TS; Verma A; Samsky MD; Donahue MP; Ilkayeva OR; Bowles DE; Patel CB; Milano CA; Rogers JG; Felker GM; O'Connor CM; Shah SH; Kraus WE
    J Am Coll Cardiol; 2016 Jan; 67(3):291-9. PubMed ID: 26796394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of integrative care on cardiovascular disease risk in newly diagnosed type 2 diabetes mellitus patients: A BI-VitalLife Cohort study.
    Khunlertkit T; Viangteeravat T; Wangprapa P; Siriwechdaruk S; Ford JM; Pongpirul K
    PLoS One; 2024; 19(5):e0302438. PubMed ID: 38809890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.